Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Industrials | 8.98% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
General Motors
GM
$80.4B
| $49.7M | 0.07% |
933,305
-1,583,117
| -63% | -$82.9M |
|
327
Madrigal Pharmaceuticals
MDGL
$10.8B
| $49.6M | 0.07% |
160,782
+116,285
| +261% | +$32.7M |
|
328
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.08B
| $49.6M | 0.07% |
1,613,100
-28,100
| -2% | -$864K |
|
329
Willis Lease Finance
WLFC
$1.7B
| $49.4M | 0.07% |
713,691
-18,300
| -3% | -$1.19M |
|
330
Aon
AON
$76.5B
| $49.3M | 0.07% |
137,401
-43,900
| -24% | -$16.1M |
|
331
Arthur J. Gallagher & Co
AJG
$64.1B
| $49.2M | 0.07% |
173,200
+82,500
| +91% | +$24M |
|
|
HSII
332
DELISTED
Heidrick & Struggles
HSII
| $49M | 0.07% |
1,106,640
+39,800
| +4% | +$1.7M |
|
333
International Paper
IP
$21.6B
| $49M | 0.07% |
910,700
+452,500
| +99% | +$24.3M |
|
334
Warby Parker
WRBY
$3.28B
| $48.5M | 0.07% |
2,002,400
+313,100
| +19% | +$6.4M |
|
335
Kyndryl
KD
$2.99B
| $48.5M | 0.07% |
1,400,367
-817,633
| -37% | -$23.8M |
|
336
Edwards Lifesciences
EW
$49.6B
| $48.3M | 0.07% |
652,493
-569,207
| -47% | -$39.8M |
|
337
Dillards
DDS
$9.19B
| $48.2M | 0.07% |
111,700
-21,600
| -16% | -$8.86M |
|
338
Motorola Solutions
MSI
$72.3B
| $48.1M | 0.07% |
104,115
+61,000
| +141% | +$28.9M |
|
|
EMBJ
339
Embraer S.A. ADS
EMBJ
$12.2B
| $47.7M | 0.07% |
1,300,500
-181,300
| -12% | -$6.53M |
|
340
Collegium Pharmaceutical
COLL
$1.15B
| $47.6M | 0.07% |
1,661,549
+5,480
| +0.3% | +$181K |
|
341
Herbalife
HLF
$1.29B
| $47.4M | 0.07% |
7,088,868
+638,567
| +10% | +$4.74M |
|
342
DuPont de Nemours
DD
$18.5B
| $47.4M | 0.07% |
495,179
-239
| -0% | -$24.9K |
|
343
VanEck IG Floating Rate ETF
FLTR
$2.94B
| $47M | 0.07% |
1,847,800
+445,800
| +32% | +$11.3M |
|
344
Emcor
EME
$35.2B
| $47M | 0.07% |
103,520
-51,155
| -33% | -$24.2M |
|
345
iShares 0-5 Year TIPS Bond ETF
STIP
$15.9B
| $46.9M | 0.07% |
466,400
+135,900
| +41% | +$13.7M |
|
346
Cisco
CSCO
$457B
| $46.6M | 0.07% |
786,705
-2,580,000
| -77% | -$147M |
|
347
Rocket Lab Corp
RKLB
$40.6B
| $46.3M | 0.07% |
1,818,800
+1,721,300
| +1,765% | +$30.2M |
|
348
Eldorado Gold
EGO
$7.87B
| $46M | 0.07% |
3,094,637
-209,000
| -6% | -$3.45M |
|
349
Carpenter Technology
CRS
$25.8B
| $46M | 0.07% |
270,900
-26,291
| -9% | -$4.51M |
|
350
Medtronic
MDT
$109B
| $46M | 0.07% |
575,341
-737,300
| -56% | -$63.8M |
|
Similar funds
Renaissance Technologies's Q4 2024 Portfolio in Review
As of Q4 2024, Renaissance Technologies held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Renaissance Technologies's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Renaissance Technologies added most to Alibaba in Q4 2024, an estimated $191M increase.
- Renaissance Technologies's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Renaissance Technologies fully exited Arm in Q4 2024, selling an estimated $153M.
- Renaissance Technologies's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Renaissance Technologies opened 548 new positions and closed 497 in Q4 2024.
- Renaissance Technologies's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.